Cancer Drug Costs 1,000x More in US Than India—But the Full Picture Is Complicated

The price gap on drugs like Imatinib is real and dramatic, rooted in India's landmark 2013 patent ruling. But the Rs 85,000-per-pill US figure is likely overstated, and most American patients pay far less out-of-pocket.

ndtv-profit-business · 7/3/2026, 6:33:24 PM · Ask about this →